No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CKPT Checkpoint Therapeutics
- 1.430
- +0.010+0.70%
Close Apr 26 16:00 ET
- 1.450
- +0.020+1.40%
Pre 08:21 ET
51.03MMarket Cap-451P/E (TTM)
1.460High1.390Low541.83KVolume1.420Open1.420Pre Close764.88KTurnover1.89%Turnover RatioLossP/E (Static)35.69MShares3.62052wk High-3.91P/B41.10MFloat Cap1.30052wk Low--Dividend TTM28.74MShs Float105.000Historical High--Div YieldTTM4.93%Amplitude1.300Historical Low1.411Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Checkpoint Therapeutics Full Year 2023 Earnings: Misses Expectations
Express News | HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target
Checkpoint Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/22/2024 1639.13% HC Wainwright & Co. → $34 Reiterates Buy → Buy 12/20/2023 104.6% B. Riley Securities $
Analysts' Top Healthcare Picks: Milestone Pharmaceuticals (MIST), Checkpoint Therapeutics (CKPT)
Checkpoint Therapeutics GAAP EPS of -$3.17 Misses by $0.49, Revenue of $0.1M Misses by $0.02M
Checkpoint Therapeutics FY23 EPS $(3.17) Vs $(7.09) YoY; As Of December 31, 2023, Checkpoint's Cash And Cash Equivalents Totaled $4.9M
Financial Results:Cash Position: As of December 31, 2023, Checkpoint's cash and cash equivalents totaled $4.9 million, compared to $12.1 million at December 31, 2022, a decrease of $7.2 million. This
Comments
FDA Lover
March 16th, the next FDA review... zzz I turn to be very interested following these FDA news
$OptiNose(OPTN.US$
when are the next date for $Checkpoint Therapeutics(CKPT.US$ , $Fortress Biotech(FBIO.US$ , and $Brainstorm Cell Therapeutics(BCLI.US$ ?
all of these stocks currently not good fundamentally... some even minus PBV
$OptiNose(OPTN.US$
when are the next date for $Checkpoint Therapeutics(CKPT.US$ , $Fortress Biotech(FBIO.US$ , and $Brainstorm Cell Therapeutics(BCLI.US$ ?
all of these stocks currently not good fundamentally... some even minus PBV
$XBI: Biotech Sector's Potential Outperformance in 2024, Especially Pre-Election Volatility in 1H
$SPDR S&P Biotech ETF(XBI.US$
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
13
1
No FDA Approval for FBIO
no news, guys I also reenter after some gains. $Fortress Biotech(FBIO.US$ . but this one actually has a lot of project, sadly it lack of cash and equity. it seems so they issue warrant monthly. DER still high. potential BEP, but a bit worried if per month issued warrant. it has position as stock holder in $Mustang Bio(MBIO.US$, $Journey Medical(DERM.US$ , $Checkpoint Therapeutics(CKPT.US$ .
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US$ by ...
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US$ by ...
2
My FDA post maybe wrong? Grrr
$Checkpoint Therapeutics(CKPT.US$ Yes CKPT got a CRL 12/18/23 for the place drug is manufactured. And partner with $Fortress Biotech(FBIO.US$ . My post came from FDA calendar as late as 1/2/24? They both have several drugs in pipeline! i try as hard as i can to post only factual information! I see no info that FBIO got any recent response from FDA? And thats why i posted. That and i seen still on calendar! So now i cant find positive information and need to delete...
2
23
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg